Methylphenidate Hydrochloride
Overview
Methylphenidate Hydrochloride is a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing levels of certain neurotransmitters in the brain.
API suppliers (6)
Suppliers of Methylphenidate Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 6 suppliers.
3 of 6 hold a GMP certificate on record in the EU or UK registers · 3 hold a European CEP for this substance
- NORAMCO INCUnited States1 active DMF
- Ipca Laboratories LimitedIndiaCEP GMP on record
- SPECGX LLCUnited StatesCEP
- SIEGFRIED EVIONNAZ SASwitzerlandCEP GMP on record
- MACFARLAN SMITH LTD GMP on record
- BOEHRINGER INGELHEIM CHEMICALS INC
EU CEP holders (11)
Companies holding a valid EU Certificate of Suitability (CEP) for Methylphenidate Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Methylphenidate Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.